Loading candles…
Astec LifeSciences Limited operates in the agrochemical industry, manufacturing agrochemical active ingredients (technical), bulk formulations, and intermediate products. The company serves the domestic Indian market and exports to multiple countries globally, with reports indicating exports to approximately 18 to 24 countries across regions including the USA, Europe, West Asia, Southeast Asia, Latin America, and Africa. It also undertakes custom synthesis projects for clients in Europe, Japan, and the US, functioning on a business-to-business basis. Astec LifeSciences is a key player in the triazole fungicides market and is a subsidiary of Godrej Agrovet Limited, which holds a 64.76% majority stake as of March 31, 2025. There are discrepancies in reported export geographies, with sources differing between 18 and 24 countries. No information on incorporation year, founders, key management, headquarters, or stock exchange listings is provided.
This page is a live market overview for ASTEC LIFESCIENCES LTD (ASTEC) on the NSE. As a listed security, ASTEC LIFESCIENCES LTD is tracked in the Chemicals segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ASTEC before placing trades on tick2trade.
As of the latest feed, ASTEC last traded at ₹620.5 on NSE, up ₹0.15 (0.02%) from the previous close of ₹620.35. Today's session range is ₹616.5 – ₹629.9, against a 52-week band of ₹513.4 – ₹941.75. Traded volume today stands at 9.45K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for ASTEC in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ASTEC is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ASTEC LIFESCIENCES LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ASTEC. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ASTEC option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 | 27 Apr 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 30 Jan 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 28 Jul 2025 |
| Other | To consider, discuss and decide various matters in connection with the Rights Issue, including the specific terms of the Rights Issue, such as the determinat… | 30 Jun 2025 |
| Fund Raising | To consider Fund Raising | 24 Jun 2025 |
| Results - Q4 & FY25 | To consider and approve the financial results for the Quarter & Financial Year ended March 31, 2025 | 23 Apr 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.